Ye C - Search Results

1

Malignancies in systemic rheumatic diseases: A mini review.

Geng Z, Ye C, Zhu X. Geng Z, et al. Among authors: ye c. Front Immunol. 2023 Feb 28;14:1095526. doi: 10.3389/fimmu.2023.1095526. eCollection 2023. Front Immunol. 2023. PMID: 36926334 Free PMC article. Review.

2

Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials.

Geng Z, Yu Y, Hu S, Dong L, Ye C. Geng Z, et al. Among authors: ye c. Clin Exp Rheumatol. 2019 Mar-Apr;37(2):318-323. Epub 2018 Aug 29. Clin Exp Rheumatol. 2019. PMID: 30183597 Free article.

3

Etanercept for Ankylosing Spondylitis With Coexisting Demyelinating Myelitis.

Ye C, Geng Z, Li S, Yu F. Ye C, et al. Am J Ther. 2019 Sep/Oct;26(5):e629-e631. doi: 10.1097/MJT.0000000000000835. Am J Ther. 2019. PMID: 30199382 No abstract available.

4

Anti-PD-1 therapy for clinical treatment of lymphoma: a single-arm meta-analysis.

Geng Z, Xiao Y, Zhu XJ, Ye C, Zhou JF. Geng Z, et al. Among authors: ye c. Oncotarget. 2018 Oct 19;9(82):35343-35355. doi: 10.18632/oncotarget.26223. eCollection 2018 Oct 19. Oncotarget. 2018. PMID: 30450162 Free PMC article.

5

α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cells.

Geng Z, Ming B, Hu S, Dong L, Ye C. Geng Z, et al. Among authors: ye c. Int Immunopharmacol. 2019 Jun;71:251-258. doi: 10.1016/j.intimp.2019.03.040. Epub 2019 Mar 28. Int Immunopharmacol. 2019. PMID: 30927735

6

The off-label uses profile of tofacitinib in systemic rheumatic diseases.

Zhao Z, Ye C, Dong L. Zhao Z, et al. Among authors: ye c. Int Immunopharmacol. 2020 Jun;83:106480. doi: 10.1016/j.intimp.2020.106480. Epub 2020 Apr 10. Int Immunopharmacol. 2020. PMID: 32283509 Review.

7

Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.

Li C, Wang XR, Ji HJ, Zhang XY, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Jin HT, Liu JT, Liu XY, Sun L, Chen HY, Wei P, Wang JX, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Han SL, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Yang XY, Li H, Huang CB, Gao M, Lai B, Li XF, Song LJ, Wang Y, Wang XY, Tang YD, Su Y, Mu R, Li ZG. Li C, et al. Among authors: ye c. Clin Rheumatol. 2017 May;36(5):1023-1029. doi: 10.1007/s10067-017-3596-7. Epub 2017 Mar 24. Clin Rheumatol. 2017. PMID: 28342151

8

Multiple Processes May Involve in the IgG4-RD Pathogenesis: An Integrative Study via Proteomic and Transcriptomic Analysis.

Cai S, Chen Y, Lin S, Ye C, Zheng F, Dong L. Cai S, et al. Among authors: ye c. Front Immunol. 2020 Aug 20;11:1795. doi: 10.3389/fimmu.2020.01795. eCollection 2020. Front Immunol. 2020. PMID: 32973752 Free PMC article.

9

Response to: 'Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China'' by Chen et al.

Zhong J, Ye C, Cai S, Dong L. Zhong J, et al. Among authors: ye c. Ann Rheum Dis. 2022 Aug;81(8):e147. doi: 10.1136/annrheumdis-2020-218508. Epub 2020 Jul 24. Ann Rheum Dis. 2022. PMID: 32709681 No abstract available.

10

COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.

Zhong J, Shen G, Yang H, Huang A, Chen X, Dong L, Wu B, Zhang A, Su L, Hou X, Song S, Li H, Zhou W, Zhou T, Huang Q, Chu A, Braunstein Z, Rao X, Ye C, Dong L. Zhong J, et al. Among authors: ye c. Lancet Rheumatol. 2020 Sep;2(9):e557-e564. doi: 10.1016/S2665-9913(20)30227-7. Epub 2020 Jul 3. Lancet Rheumatol. 2020. PMID: 32838309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,940 results

Search Page